Qi Zheng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Irritable Bowel Syndrome

Systematic Review

Mesenchymal Stem Cells

Top Venues

Interactive journal of medical research

This page only lists publications with an associated author ORCID identifier.

Publications

Jiali Ni, Yong Huang, Qiangqiang Xiang, Qi Zheng, Xiang Xu, Zhiwen Qin, Guoping Sheng, Lan-Juan Li
Establishment and Evaluation of a Noninvasive Metabolism-Related Fatty Liver Screening and Dynamic Monitoring Model: Cross-Sectional Study. Interactive journal of medical research 13 (2024)
Youhe Wu, Yuetong Li, Qi Zheng, Lanjuan Li
The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients 16 (13) (2024)
Jiali Ni, Yong Huang, Qiangqiang Xiang, Qi Zheng, Xiang Xu, Zhiwen Qin, Guoping Sheng, Lan-Juan Li
Establishment and Evaluation of a Noninvasive Metabolism-Related Fatty Liver Screening and Dynamic Monitoring Model: Cross-Sectional Study. Interactive journal of medical research 13 (2024)
Youhe Wu, Yuetong Li, Qi Zheng, Lanjuan Li
The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients 16 (13) (2024)
Qi Zheng, Yuetong Li, Guoping Sheng, Lanjuan Li
The Value of Ursodeoxycholic Acid and Mesenchymal Stem Cells in the Treatment of Severe COVID-19. Microorganisms 12 (7) (2024)
Qi Zheng, Yuetong Li, Guoping Sheng, Lanjuan Li
The Value of Ursodeoxycholic Acid and Mesenchymal Stem Cells in the Treatment of Severe COVID-19. Microorganisms 12 (7) (2024)
Youhe Wu, Yuetong Li, Qi Zheng, Lanjuan Li
The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Nutrients 16 (13) (2024)
Qi Zheng, Yuetong Li, Guoping Sheng, Lanjuan Li
The Value of Ursodeoxycholic Acid and Mesenchymal Stem Cells in the Treatment of Severe COVID-19. Microorganisms 12 (7) (2024)